Has post-COVID-19 increased CTEPD rates? A prospective study on persistent dyspnea and risk factors

Back

ESC2025 Premium Access

Has post-COVID-19 increased CTEPD rates? A prospective study on persistent dyspnea and risk factors

Session: Venous thromboembolism

Topic: Pulmonary Hypertension

Speaker: Doctor L. Alajbegovic (Vienna, AT)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Leila Alajbegovic

Medical University of Vienna, Vienna (Austria)

0 follower

7 more presentations in this session

Impact of reasons for discontinuing anticoagulation therapy on clinical outcomes in patients with venous thromboembolism: insight from the COMMAND VTE Registry-2

Speaker: Doctor M. Kinugawa (Toyonaka, JP)

Statin therapy for the prevention of venous thromboembolism in cancer patients: a systematic review and meta-analysis

Speaker: Doctor F. Catalani (Bellinzona, CH)

Impact of thrombocytopenia on clinical outcomes in patients with cancer-associated isolated distal deep vein thrombosis: Insights from the ONCO DVT Study

Speaker: Doctor Y. Miyoshi (Kyoto, JP)

The predictive value of estimated glucose disposal rate for the risk of venous thromboembolism in elderly individuals: a prospective cohort study of UK biobank

Speaker: Doctor Y. Zheng (Tianjin, CN) Doctor T. Liu (Tianjin, CN)

Comparison of hospital and home treatment for symptomatic proximal deep vein thrombosis: from theCOMMAND VTE Registry-2

Speaker: Mr K. Mushiake (Kurashiki, JP)

Access the full session

Venous thromboembolism

Speakers: Doctor L. Alajbegovic, Doctor M. Kinugawa, Doctor F. Catalani, Doctor Y. Miyoshi, Doctor Y. Zheng...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources